Date published: 2026-9-15

1-800-457-3801

SCBT Portrait Logo
Seach Input

DnaJC8 Inhibitors

DnaJC8 inhibitors encompasses a distinctive group of chemical entities designed to modulate the activity of the DnaJC8 protein, which belongs to the DnaJ family of molecular chaperones. The DnaJ family proteins play a pivotal role in orchestrating various cellular processes by assisting in the correct folding, assembly, and disassembly of other proteins. Within this context, DnaJC8, also known as DNAJC8 or DNAJ homolog subfamily C member 8, emerges as a significant player in cellular protein quality control and homeostasis. DnaJC8 is recognized for its involvement in mediating protein-protein interactions, where it acts as a chaperone to stabilize protein conformations or facilitate their timely degradation. These interactions are essential for ensuring the proper folding of nascent proteins, as well as for assisting damaged or misfolded proteins to regain their functional structure or be targeted for degradation by cellular machinery. DnaJC8 achieves its chaperone activity through binding to unfolded or partially folded protein substrates, thus preventing their aggregation and aiding in their refolding or degradation. DnaJC8 inhibitors are meticulously designed molecules intended to selectively interfere with the activity of DnaJC8. By binding to specific regions of the protein or altering its conformation, these inhibitors may modulate the protein's chaperone function, thereby influencing its interactions with client proteins. This, in turn, has the potential to impact a range of cellular processes that rely on DnaJC8-mediated protein folding and stabilization. The study and application of DnaJC8 inhibitors hold promise for deciphering the intricate network of protein quality control and chaperone-mediated mechanisms within the cell. These compounds serve as invaluable tools in research endeavors aimed at unraveling the precise roles and molecular mechanisms associated with DnaJC8.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Cisplatin

15663-27-1sc-200896
sc-200896A
100 mg
500 mg
$138.00
$380.00
101
(4)

Forms covalent adducts with DNA, leading to DNA cross-linking and inhibition of DNA replication and transcription.

Oxaliplatin

61825-94-3sc-202270
sc-202270A
5 mg
25 mg
$112.00
$394.00
8
(1)

Similar to cisplatin, forms DNA adducts and interferes with DNA replication and transcription.

Mitomycin C

50-07-7sc-3514A
sc-3514
sc-3514B
2 mg
5 mg
10 mg
$66.00
$101.00
$143.00
85
(5)

Cross-links DNA strands, leading to DNA damage and inhibition of DNA synthesis.

Camptothecin

7689-03-4sc-200871
sc-200871A
sc-200871B
50 mg
250 mg
100 mg
$58.00
$186.00
$94.00
21
(2)

Inhibits topoisomerase I, trapping it on DNA and causing single-strand breaks during replication.

Etoposide (VP-16)

33419-42-0sc-3512B
sc-3512
sc-3512A
10 mg
100 mg
500 mg
$51.00
$231.00
$523.00
63
(1)

Targets topoisomerase II, causing DNA strand breaks and inhibition of DNA repair and replication.

Doxorubicin

23214-92-8sc-280681
sc-280681A
1 mg
5 mg
$176.00
$426.00
43
(3)

Intercalates into DNA, inhibiting topoisomerase II and causing DNA damage and strand breaks.

2′-Deoxy-2′,2′-difluorocytidine

95058-81-4sc-275523
sc-275523A
1 g
5 g
$56.00
$128.00
(1)

Incorporates into DNA and inhibits DNA synthesis, leading to chain termination during replication.

Fludarabine

21679-14-1sc-204755
sc-204755A
5 mg
25 mg
$58.00
$204.00
15
(1)

Inhibits DNA synthesis by interfering with ribonucleotide reductase and DNA polymerase.

Topotecan

123948-87-8sc-338718
100 mg
$582.00
(0)

Targets topoisomerase I, causing DNA breaks and inhibiting DNA repair and replication.

Idarubicin

58957-92-9sc-507346
10 mg
$180.00
(0)

Similar to daunorubicin, intercalates into DNA and inhibits topoisomerase II.